CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in XML Financial, LLC  ·  22 quarters on record

This page tracks every 13F SEC filing in which XML Financial, LLC reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2022 Q4)
Avg. % of fund
0.04%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
22
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 10,000 — 0% 0.02% $197K $19.70
2025 Q2 UNCHANGED 10,000 — 0% 0.02% $217K $21.70
2025 Q1 REDUCED 10,000 -20,000 -66.7% 0.02% $242K $24.25
2024 Q4 UNCHANGED 30,000 — 0% 0.06% $626K $20.87
18 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CPRX price (monthly, adj. close)

Other funds also holding CPRX

As of 2025 Q4 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to XML Financial, LLC Holdings